Intuitive Surgical, Inc. (ISRG) closed at $426.61 in the latest trading session, marking a +1.91% move from the prior day. This change outpaced the S&P 500's 0.26% loss on the day. Meanwhile, the Dow experienced a rise of 0.17%, and the technology-dominated Nasdaq saw a decrease of 0.97%.
The company's shares have seen a decrease of 0.35% over the last month, not keeping up with the Medical sector's gain of 3.5% and the S&P 500's gain of 0.23%.
Market participants will be closely following the financial results of Intuitive Surgical, Inc. in its upcoming release. On that day, Intuitive Surgical, Inc. is projected to report earnings of $2.48 per share, which would represent year-over-year growth of 13.24%. At the same time, our most recent consensus estimate is projecting a revenue of $2.81 billion, reflecting a 15% rise from the equivalent quarter last year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $10.4 per share and revenue of $11.72 billion, which would represent changes of +16.46% and +16.47%, respectively, from the prior year.
It is also important to note the recent changes to analyst estimates for Intuitive Surgical, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 0.01% higher. Right now, Intuitive Surgical, Inc. possesses a Zacks Rank of #2 (Buy).
From a valuation perspective, Intuitive Surgical, Inc. is currently exchanging hands at a Forward P/E ratio of 40.25. This expresses a premium compared to the average Forward P/E of 22.55 of its industry.
Investors should also note that ISRG has a PEG ratio of 2.75 right now. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As the market closed yesterday, the Medical - Instruments industry was having an average PEG ratio of 2.07.
The Medical - Instruments industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 154, placing it within the bottom 37% of over 250 industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Intuitive Surgical, Inc. (ISRG): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).